Article
Increased serum IL-17 is an independent risk factor for severe asthma.
Respiratory medicine - 1 Aug 2010
Agache Ioana, Ciobanu Cristina, Agache Costel, Anghel Mariana
Abstract excerpt
BACKGROUND: IL-17 expression was found to be associated with many inflammatory diseases in humans, such as rheumatoid arthritis, asthma, systemic lupus erythematosus and allograft rejection and many in vitro studies have indicated a proinflammatory function for IL-17. OBJECTIVE: Prognostic value of increased serum IL-17 in asthma patients. METHODS: Serum IL-17 (ELISA) was measured in 85 asthma patients (pts),...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
